Many men with stable heart disease can use erectile dysfunction medicines such as sildenafil or tadalafil safely, but not every cardiac patient should self-start them. The key questions are whether sexual activity itself is safe, whether the heart condition is stable, and whether nitrate medicines or nicorandil are being used. PDE5 inhibitors must not be combined with nitrates because blood pressure can fall dangerously. Men with unstable angina, uncontrolled symptoms, recent serious cardiac events or uncertain exercise tolerance should be assessed before ED treatment. ED can also be an early marker of vascular disease, so the heart-health assessment is part of ED care.

Why are ED and heart disease connected?

An erection depends on healthy blood vessels. The same processes that narrow coronary arteries – smoking, diabetes, high blood pressure, high cholesterol, obesity and vascular inflammation – can impair penile blood flow.

Because penile arteries are smaller, erectile difficulty may appear before obvious coronary symptoms in some men. Modern consensus statements therefore treat vasculogenic ED as a cardiovascular risk marker, not just a sexual symptom.

Are sildenafil and tadalafil bad for the heart?

For appropriately selected patients, PDE5 inhibitors have a reassuring cardiovascular safety record. Clinical trials have not shown that these drugs increase myocardial infarction rates, and studies in men with stable angina have not shown worsening of exercise-induced ischaemia. The medicine is often not the main issue; the stability of the heart disease and the presence of interacting drugs are.

The bigger safety issue is whether the patient has a stable cardiovascular condition and whether interacting vasodilator drugs are being used.

Who is usually considered lower risk?

Men with stable, well-controlled cardiovascular disease who can perform moderate physical activity without chest pain, marked breathlessness, fainting or other limiting symptoms are often in a lower-risk group for sexual activity. A coronary stent or a past cardiac diagnosis by itself does not automatically rule out ED treatment.

The exact risk category depends on the cardiac diagnosis, recent symptoms, blood pressure, heart failure status, rhythm problems and exercise capacity.

Who needs cardiac review before ED medicines?

• Unstable or worsening angina.
• Chest pain with minimal activity or during sex.
• Recent heart attack, stroke or major cardiac procedure when recovery status is uncertain.
• Poorly controlled heart failure or significant breathlessness at low activity levels.
• Uncontrolled arrhythmia, very low blood pressure or uncontrolled severe hypertension.
• Uncertain exercise tolerance in a patient with several cardiovascular risk factors.
• Any patient in whom a doctor has advised avoiding sexual activity until the heart condition is stabilised.

Nitrates: the absolute contraindication

Organic nitrates such as nitroglycerin/glyceryl trinitrate and isosorbide preparations must not be combined with PDE5 inhibitors. Recreational nitrate poppers are also unsafe. Nicorandil has nitrate-like nitric-oxide donating action and is likewise considered contraindicated.

As a general safety interval, nitrates are avoided for at least 24 hours after shorter-acting PDE5 inhibitors such as sildenafil and for at least 48 hours after tadalafil. In an emergency, the treating team must decide the safest approach based on the exact drug, timing, dose and clinical situation. This is why the ED medicine and time taken should always be disclosed.

What if I carry a nitrate but rarely use it?

Do not decide on your own that the interaction does not matter. Some stable coronary patients carry nitrates they no longer need, while others depend on them. Princeton IV recommends reviewing whether the nitrate is still required and whether an alternative cardiac strategy is possible. That decision belongs with the treating cardiac physician.

Never stop an essential cardiac medicine just to take an ED tablet.

What if chest pain occurs after taking sildenafil or tadalafil?

Stop sexual activity and seek urgent medical care. Tell the medical team exactly which ED medicine you used and when. Do not take sublingual nitrate medication on your own because the combination can produce profound hypotension.

Chest pain should be treated as a cardiac symptom first. ED management can be revisited once the cardiovascular condition is stable.

ED can be a reason to check cardiovascular risk

A man presenting with new vasculogenic ED, especially after age 40 or with diabetes, hypertension, smoking, high cholesterol or a strong family history, should have cardiovascular risk factors assessed. Depending on risk, this may include blood pressure, glucose/HbA1c, lipid profile and a formal cardiovascular risk estimate.

Some men whose calculated cardiovascular risk is borderline or intermediate may benefit from further cardiac risk assessment, which can include coronary artery calcium scoring. This is not a routine ED test for everyone; it is a selective cardiology decision when the result would change risk classification or treatment.

Can ED medicines be used after a heart attack?

There is no single calendar rule that makes every man “safe” after a heart attack. Recovery, residual angina, heart-failure status, rhythm stability, exercise capacity, rehabilitation progress and current medicines matter. A stable man may later return to sexual activity and ED treatment; a man with ongoing symptoms should not use an ED tablet as a test of whether his heart can tolerate sex.

What other ED treatments are available if PDE5 inhibitors are unsuitable?

• Vacuum erection device for selected men wanting a non-drug option.
• Intracavernosal injection therapy after proper training.
• Psychosexual therapy when anxiety or relationship factors contribute.
• Treatment of testosterone deficiency only when clinically and biochemically confirmed.
• Penile implant surgery for men who prefer a definitive option or fail/are unsuitable for less-invasive treatments.

What to bring for consultation

• List of all cardiac medicines, especially nitrates and nicorandil.
• Cardiology discharge summaries, angiography/stent/bypass records if relevant.
• Recent ECG/echo/stress-test reports if done.
• Blood pressure readings.
• Diabetes and lipid reports.
• Details of chest pain, breathlessness or exercise limitation.
• The ED medicine previously tried and whether any symptoms occurred.

FAQs

Related reading

• ED Medicines with BP Tablets
• Sildenafil vs Tadalafil: Difference Explained
• Side Effects of ED Medicines
• Erectile Dysfunction After 40
• Erectile Dysfunction in Diabetic Men
• Blood Tests for Erectile Dysfunction
• Urologist in Latur

References

• European Association of Urology. EAU Guidelines on Sexual and Reproductive Health – Management of Erectile Dysfunction (2026) https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/management-of-erectile-dysfunction
• Kloner RA, et al. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. J Sex Med. 2024;21(2):90-116 https://academic.oup.com/jsm/article/21/2/90/7499332